The tournament involves amateur players — a roster of celebrities, sports stars and business leaders — playing alongside the ...

Fintel reports that on January 31, 2025, Stifel upgraded their outlook for C.H. Robinson Worldwide (NasdaqGS:CHRW) from Hold ...

Stifel analysts revised the price target for Kirby Corporation (NYSE:KEX) stock, reducing it slightly to $135 from the ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

Stifel lowered the firm’s price target on Intel (INTC) to $21 from $25 and keeps a Hold rating on the shares. Q4 results were above management ...

Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Altria Group (MO – Research Report) today and set a price target of ...

Stifel analyst David Grossman raised the firm’s price target on IBM (IBM) to $271 from $246 and keeps a Buy rating on the ...

Stifel analyst Chris O’Cull raised the firm’s price target on Brinker (EAT) to $200 from $170 and keeps a Buy rating on the shares after what the firm calls “another stellar quarter.” The results are ...

While total segment revenue declined 6.6% year-over-year due to weak truckload (TL) demand and lower rates, gross margins ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.